Admera Health Launches New Tests for Cancer Supportive Care and Liquid Biopsy, Now Provides a Comprehensive Portfolio of Oncology Products
October 31, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health (www.admerahealth.com) announced the launch of multiple laboratory developed tests: PGxOnco™, for cancer supportive...
Admera Health Expands Asian Footprint with Three Strategic Partnerships
September 12, 2017 11:05 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Today, Admera Health announced agreements expanding Admera’s portfolio of molecular diagnostics to Asia, including but not limited to...
New York Medical College and Touro College of Pharmacy Team to Offer Pharmacogenomics CME Course Sponsored by Admera Health
August 08, 2017 09:59 ET
|
Admera Health, LLC
VALHALLA, N.Y. and SOUTH PLAINFIELD, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Today, New York Medical College and Touro College of Pharmacy announced the wider availability of their joint Continuing...
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
July 25, 2017 19:00 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 25, 2017 (GLOBE NEWSWIRE) -- Admera Health, an advanced molecular diagnostic laboratory, has been selected by Columbia University Medical Center’s Center for Biomedical...
Admera Health Partners with Helix to Launch Genetic Tests to Assess the Risk of Inherited High Cholesterol, Sudden Cardiac Death, and Inherited Diabetes
July 24, 2017 07:45 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., July 24, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for the risk assessment and early diagnosis of...
Associates in Cardiovascular Disease and Admera Health Unveiled a Health Economics Model at the 2017 National Lipid Association Conference Detailing the Cost Benefits of Genetic Testing for Familial Hypercholesterolemia
May 23, 2017 09:25 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 23, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for risk assessment and early diagnosis of...
Internationally Recognized Pharmacogenomic Expert Dr. Howard McLeod Joins Admera Health’s Advisory Board
May 17, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Advanced Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today the appointment of Howard McLeod, PharmD to its...
University of Rochester School of Medicine and Dentistry Collaborate with Admera Health in a Clinical Study, Evaluating Pharmacogenomics in Acute Surgical Pain Management
May 09, 2017 09:13 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J. and ROCHESTER, N.Y., May 09, 2017 (GLOBE NEWSWIRE) -- Today, the University of Rochester School of Medicine and Dentistry and Admera Health announced that enrollment had...
Health in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic Cardiomyopathies
May 03, 2017 09:13 ET
|
Admera Health, LLC
A CORUÑA, Spain and SOUTH PLAINFIELD, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Today, Health in Code (HiC), (www.healthincode.com) a thought leader in the genetic cardiovascular field announced...
Admera Health Reaches Yet Another Significant Milestone, by Achieving New CLEP Approval for PGxOne™ Plus, a 50 Gene Pharmacogenomics Test
March 16, 2017 10:31 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Advanced Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that its PGxOne™ Plus has received New...